Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Feasibility Study (EFS) to Assess the Safety and Performance of the Innoventric Trillium™ Stent Graft in the Treatment of Severe or Greater Tricuspid Regurgitation (TR)

NCT06212193 is registered in ClinicalTrials.gov with Innoventric LTD as lead sponsor.

NCT NCT06212193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06212193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Feasibility Study (EFS) to Assess the Safety and Performance of the Innoventric Trillium™ Stent Graft in the Treatment of Severe or Greater Tricuspid Regurgitation (TR)
Lead sponsor
Innoventric LTD
Phase
Not applicable
Overall status
Recruiting
Start date
August 5, 2024
Completion date
August 31, 2030
Enrollment
15 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

tricuspid regurgitation, tricuspid regurgitation functional